Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty

Abstract

BackgroundEstimates of disease incidence and prevalence are core indicators of public health. The manner in which these indicators stand out against each other provide guidance as to which diseases are most common and what health problems deserve priority. Our aim was to investigate how routinely collected data from different general practitioner registration networks (GPRNs) can be combined to estimate incidence and prevalence of chronic diseases and to explore the role of uncertainty when comparing diseases.MethodsIncidence and prevalence counts, specified by gender and age, of 18 chronic diseases from 5 GPRNs in the Netherlands from the year 2007 were used as input. Generalized linear mixed models were fitted with the GPRN identifier acting as random intercept, and age and gender as explanatory variables. Using predictions of the regression models we estimated the incidence and prevalence for 18 chronic diseases and calculated a stochastic ranking of diseases in terms of incidence and prevalence per 1,000.ResultsIncidence was highest for coronary heart disease and prevalence was highest for diabetes if we looked at the point estimates. The between GPRN variance in general was higher for incidence than for prevalence. Since uncertainty intervals were wide for some diseases and overlapped, the ranking of diseases was subject to uncertainty. For incidence shifts in rank of up to twelve positions were observed. For prevalence, most diseases shifted maximally three or four places in rank.ConclusionEstimates of incidence and prevalence can be obtained by combining data from GPRNs. Uncertainty in the estimates of absolute figures may lead to different rankings of diseases and, hence, should be taken into consideration when comparing disease incidences and prevalences.

Development of the Andalusian Registry of Patients Receiving Community Case Management, for the follow‐up of people with complex chronic diseases

“…The existence of a clinical registry of patients with complex chronic diseases who receive case management is an important innovation not only in the PHCSA, but also at an international level. At present, there are registries for selected chronic conditions such as diabetes [37,38], stroke [39], heart disease [40], asthma [41]or the attempt to obtain the prevalence and incidence of chronic diseases from usual clinical records [42], but not in the case of multimorbid patients with multiple conditions who receive case management. This novel approach will permit a complete and in‐depth analysis of the characteristics of the patients who receive this service, the interventions delivered and some major outcomes as mortality, readmissions, or adverse events.…”

The Added Value of Medical Testing in Underwriting Life Insurance

“…This can probably be explained by the fact that 90% of all diabetes is diabetes type II. Diabetes type II is more prevalent with increasing age [ 23 , 24 ]. Additionally, the association between BMI and diabetes type II is complex as patients with diabetes type II appear to vary greatly in pattern and to the degree of overweight at the time of diagnoses [ 25 ].…”

Estimating incidence and prevalence rates of chronic diseases using disease modeling

“…Third degree polynomials were considered for age and for the interaction of age with sex. We selected the simplest model that fitted the data statistically significantly better than all other models (for more detail on this method see [5]).…”

“…Incidence, prevalence, and mortality are consistent if the prevalence is a credible function of inflow (incidence) and outflow (institutionalization and mortality), taking the possibility of time trends into account. Consistent estimates are needed for chronic disease modeling [5]. Furthermore, consistency improves the reliability of the incidence and prevalence estimates.…”